Delivra Health Brands to Hold Conference Call to Discuss Annual Financial Results for the Fiscal Year Ending June 30, 2023
- Delivra Health Brands Inc. will report its annual financial results for the fiscal year ending June 30, 2023 on October 18, 2023.
- None.
Vancouver, British Columbia--(Newsfile Corp. - October 13, 2023) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) (Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce it will report its annual financial results for the fiscal year ending June 30, 2023 on Wednesday, October 18, 2023, before the market opens.
Conference Call Details
The Company will host a conference call on Wednesday, October 18, 2023, at 11:00 a.m. (EDT) / 8:00 a.m. (PDT) to discuss the Company's financial results for the fiscal year ending June 30, 2023. Gord Davey, President and Chief Executive Officer, and Jack Tasse, Chief Financial Officer of the Company will be conducting a question-and-answer session following management's prepared remarks.
Participant Dial-In Numbers:
All interested parties can join the conference call by dialing: 1-800-319-4610 (Canada/USA Toll Free) or 1-604-638-5340 (International Toll). Please dial in 10 minutes prior to the scheduled start time and ask to join the Delivra Health call. A replay of the call will be available on the Company's investor page on its website at www.delivrahealthbrands.com/investors/quarterly-calls/ by the end of the business day on Wednesday, October 18, 2023.
About Delivra Health Brands Inc.
Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water® and LivRelief™, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are Dream Water® and LivReliefTM. For more information, please visit www.delivrahealthbrands.com.
Cautionary Note Regarding Forward-Looking Statements
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to the timing of reporting the Company's annual financial results for the fiscal year ending June 30, 2023, the timing of the conference call, and the availability of the replay of the conference call.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Company's management's discussion and analysis dated May 23, 2023, for the three and nine months ended March 31, 2023, filed under the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/183781
FAQ
When will Delivra Health Brands Inc. report its annual financial results?
What time is the conference call to discuss the financial results?
Who will be conducting the question-and-answer session during the conference call?
How can I join the conference call?
Will there be a replay of the call available?
